Journal article
Antiplatelet Drugs Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
Abstract
The article describes the mechanisms of action, pharmacokinetics, and pharmacodynamics of aspirin, dipyridamole, cilostazol, the thienopyridines, and the glycoprotein IIb/IIIa antagonists. The relationships among dose, efficacy, and safety are discussed along with a mechanistic overview of results of randomized clinical trials. The article does not provide specific management recommendations but highlights important practical aspects of …
Authors
Eikelboom JW; Hirsh J; Spencer FA; Baglin TP; Weitz JI
Journal
CHEST Journal, Vol. 141, No. 2, pp. e89s–e119s
Publisher
Elsevier
Publication Date
February 2012
DOI
10.1378/chest.11-2293
ISSN
0012-3692
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
AspirinCilostazolDipyridamoleDose-Response Relationship, DrugDrug Therapy, CombinationEvidence-Based MedicineHumansPlatelet ActivationPlatelet AggregationPlatelet Aggregation InhibitorsPlatelet Glycoprotein GPIIb-IIIa ComplexPractice Guidelines as TopicRandomized Controlled Trials as TopicSocieties, MedicalTetrazolesThienopyridinesThrombosisUnited States